Literature DB >> 21039223

Hemojuvelin and hepcidin genes sequencing in Brazilian patients with primary iron overload.

Paulo Caleb Júnior de Lima Santos1, Alexandre C Pereira, Rodolfo D Cançado, Isolmar T Schettert, Rosario D C Hirata, Mario H Hirata, Maria Stella Figueiredo, Carlos S Chiattone, Jose E Krieger, Elvira M Guerra-Shinohara.   

Abstract

BACKGROUND: most hereditary hemochromatosis (HH) patients are homozygous for the p.C282Y mutation in the HFE gene. Some studies reported that HH phenotypic expression could be modulated by genetic factors such as HJV and HAMP gene mutations. AIMS: the aims of this study were to identify HJV and HAMP mutations and to analyze their impact on HH phenotype in non-p.C282Y homozygous individuals.
METHODS: Twenty-four Brazilian patients with primary iron overload and non-p.C282Y homozygous genotype (transferrin saturation >50% in women and >60% in men and absence of secondary causes) were selected. Subsequent bidirectional sequencing of the HJV and HAMP exons was performed.
RESULTS: sequencing revealed a substitution in heterozygosis, c.929C > G, which corresponds to p.A310G polymorphism in HJV exon 4 (rs7540883). In the same gene, in another individual, an IVS1-36C > G intronic variant was detected in heterozygosis. In the HAMP gene, an IVS3 + 42G > A intronic variant was identified. There were six (25.0%) patients carrying a heterozygous genotype for the HFE p.C282Y and nine (37.5%) patients carrying a heterozygous genotype for the HFE p.H63D.
CONCLUSION: HJV p.A310G polymorphism and two intronic variants were found, but none of these alterations were associated with digenic inheritance with the HFE gene. Our data indicate that HJV and HAMP functional mutations are not frequent in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039223     DOI: 10.1089/gtmb.2010.0056

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  6 in total

1.  Non-HFE hemochromatosis.

Authors:  Paulo Caleb Júnior de Lima Santos; Carla Luana Dinardo; Rodolfo Delfini Cançado; Isolmar Tadeu Schettert; José Eduardo Krieger; Alexandre Costa Pereira
Journal:  Rev Bras Hematol Hemoter       Date:  2012

Review 2.  Molecular diagnostic and pathogenesis of hereditary hemochromatosis.

Authors:  Paulo C J L Santos; Jose E Krieger; Alexandre C Pereira
Journal:  Int J Mol Sci       Date:  2012-02-01       Impact factor: 6.208

Review 3.  Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis.

Authors:  Amanda B Core; Susanna Canali; Jodie L Babitt
Journal:  Front Pharmacol       Date:  2014-05-13       Impact factor: 5.810

4.  Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis.

Authors:  Paula Fernanda Silva Fonseca; Rodolfo Delfini Cançado; Flavio Augusto Naoum; Carla Luana Dinardo; Guilherme Henrique Hencklain Fonseca; Sandra Fatima Menosi Gualandro; José Eduardo Krieger; Alexandre Costa Pereira; Pierre Brissot; Paulo Caleb Junior Lima Santos
Journal:  BMC Med Genet       Date:  2018-01-05       Impact factor: 2.103

5.  Hemochromatosis in India: First Report of Whole Exome Sequencing With Review of the Literature.

Authors:  Abraham Koshy; Roy J Mukkada; Antony P Chettupuzha; Jose V Francis; Julio C Kandathil; Pushpa Mahadevan
Journal:  J Clin Exp Hepatol       Date:  2019-04-29

6.  Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period.

Authors:  Luis Alfredo Utria Acevedo; Aline Morgan Alvarenga; Paula Fernanda Silva Fonseca; Nathália Kozikas da Silva; Rodolfo Delfini Cançado; Flavio Augusto Naoum; Carla Luana Dinardo; Alexandre Costa Pereira; Pierre Brissot; Paulo Caleb Junior Lima Santos
Journal:  Genes (Basel)       Date:  2022-01-10       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.